PIA
AGIO icon

Piedmont Investment Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

Piedmont Investment Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,431
Closed -$231K – 941
2019
Q1 		$231K Buy
+3,431
New +$200K 0.01% 986
2018
Q4 		– Sell
-3,424
Closed -$264K – 1038
2018
Q3 		$264K Buy
3,424
+3,423
+342,300% +$275K 0.01% 841
2018
Q2 		$0 Buy
+1
New +$87 ﹤0.01% 2874

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Piedmont Investment Advisors's AGIO Position: Q2 2019 in Review

Piedmont Investment Advisors sold out of Agios Pharmaceuticals (AGIO) in Q2 2019, closing a stake of 3,431 shares — an estimated $231K sold.

Piedmont Investment Advisors first reported a position in AGIO in Q2 2018 and held it in 3 quarters. The position peaked at $264K in Q3 2018. 189 funds tracked by Wall St. Rank hold AGIO as of Q2 2019.

  • Piedmont Investment Advisors reported no remaining Agios Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Piedmont Investment Advisors sold 3,431 Agios Pharmaceuticals shares in Q2 2019, an estimated $231K.
  • Piedmont Investment Advisors first reported a position in Agios Pharmaceuticals in Q2 2018 and held it in 3 quarters.
  • Piedmont Investment Advisors's Agios Pharmaceuticals position peaked at $264K in Q3 2018.
  • 189 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2019.

Based on Piedmont Investment Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.